This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992 Feb;10(2):180-99.

doi: 10.1200/JCO.1992.10.2.180.

Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer

S A Rosenberg¹

Affiliations

PMID: 1732421
DOI: 10.1200/JCO.1992.10.2.180

Review

Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer

S A Rosenberg. J Clin Oncol. 1992 Feb.

. 1992 Feb;10(2):180-99.

doi: 10.1200/JCO.1992.10.2.180.

Author

S A Rosenberg¹

Affiliation

¹ National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

PMID: 1732421
DOI: 10.1200/JCO.1992.10.2.180

No abstract available

PubMed Disclaimer

Similar articles

Adoptive immunotherapy with recombinant interleukin 2, LAK and TIL.
Kurnick JT, Kradin RL. Kurnick JT, et al. Allergol Immunopathol (Madr). 1991 Sep-Oct;19(5):209-14. Allergol Immunopathol (Madr). 1991. PMID: 1811418 Review. No abstract available.
[Adoptive immunotherapy in patients with multiple hepatic cancers using lymphokine activated killer cells (LAK) and interleukin-2].
Kanai T, Monden M, Takeda T, Gotoh M, Sakon M, Umeshita K, Hasuike Y, Sakita I, Nakano H, Yoshida T, et al. Kanai T, et al. Gan To Kagaku Ryoho. 1993 Aug;20(11):1457-60. Gan To Kagaku Ryoho. 1993. PMID: 8396896 Japanese.
Interleukin 2 in cancer therapy.
Testa U, Montesoro E, Bulgarini D, Samoggia P, Masciulli R, Habetswallner D, Carè A, Mariani G, Giannella G, Boccoli G, et al. Testa U, et al. Ann Ist Super Sanita. 1990;26(3-4):283-334. Ann Ist Super Sanita. 1990. PMID: 2091501 Review.
Therapy with interleukin-2 and tumor-derived activated lymphocytes.
Oldham RK. Oldham RK. Immunol Ser. 1994;61:251-71. Immunol Ser. 1994. PMID: 8011748 Review. No abstract available.
Adoptive immunotherapy of advanced solid tumors: an eight year clinical experience.
Semino C, Martini L, Queirolo P, Cangemi G, Costa R, Alloisio A, Ferlazzo G, Sertoli MR, Reali UM, Ratto GB, Melioli G. Semino C, et al. Anticancer Res. 1999 Nov-Dec;19(6C):5645-9. Anticancer Res. 1999. PMID: 10697634 Review.

See all similar articles

Cited by

A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma.
Gaugler B, Brouwenstijn N, Vantomme V, Szikora JP, Van der Spek CW, Patard JJ, Boon T, Schrier P, Van den Eynde BJ. Gaugler B, et al. Immunogenetics. 1996;44(5):323-30. doi: 10.1007/BF02602776. Immunogenetics. 1996. PMID: 8781117
Adoptive immunotherapy with peripheral blood lymphocytes cocultured in vitro with autologous tumor cells and interleukin-2.
Sporn JR, Ergin MT, Robbins GR, Cable RG, Silver H, Mukherji B. Sporn JR, et al. Cancer Immunol Immunother. 1993 Aug;37(3):175-80. doi: 10.1007/BF01525432. Cancer Immunol Immunother. 1993. PMID: 8392912 Free PMC article. Clinical Trial.
Immunomodulation following chemotherapy.
Obadina M, Verma U, Hawkins M, Mazumder A. Obadina M, et al. Breast Cancer Res Treat. 1996;38(1):41-8. doi: 10.1007/BF01803782. Breast Cancer Res Treat. 1996. PMID: 8825121 Review.
Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis.
Andersen SN, Rognum TO, Lund E, Meling GI, Hauge S. Andersen SN, et al. Br J Cancer. 1993 Jul;68(1):80-5. doi: 10.1038/bjc.1993.290. Br J Cancer. 1993. PMID: 8318425 Free PMC article.
Strategies for cancer gene therapy using adenoviral vectors.
Descamps V, Duffour MT, Mathieu MC, Fernandez N, Cordier L, Abina MA, Kremer E, Perricaudet M, Haddada H. Descamps V, et al. J Mol Med (Berl). 1996 Apr;74(4):183-9. doi: 10.1007/BF00204748. J Mol Med (Berl). 1996. PMID: 8740649 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information